ALFA FinderBSE filing, NSE: CENTRALBK. Summary written from the filing by ALFA Finder's alert engine.
Central Bank of India: key numbers
- Share price
- ₹31.23
- Market cap
- ₹28,268 Cr
- Revenue (annual)
- ₹36,168 Cr
- Net profit (annual)
- ₹4,524 Cr
- P/E (TTM)
- 5.9×Sector 20.5×
- Promoter holding
- 81.19%+0.00% QoQ
- FII holding
- 1.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Central Bank of India
All →Central Bank of India Management Change
Central Bank of India reported that Ms. Poppy Sharma, Chief General Manager, ceases to be a Senior Management Personnel after superannuation on 31 October 2026. This is a senior management departure.
Central Bank of India Adverse Business Impact
Central Bank of India reported a technical glitch in its RTGS outward system between October 15-17, 2026. The bank confirmed no customer suffered financial losses.
Central Bank of India Earnings Call Transcript: Key Takeaways
Central Bank of India delivered strong growth across RAM segments, significantly exceeding its own annual business and advances guidance.
Central Bank of India Results Update
Central Bank of India reported a 21.10% YoY increase in net profit to ₹1,469 crore for Q2 FY27. Total global business grew 20.54% to ₹8,89,541 crore.
- Value
- ₹1,469 Cr
- total branches
- 4622.0 branches
Central Bank of India Q2 FY27 Results: Net Profit ₹1,486 Cr, Up 20.6% YoY
Central Bank of India reported revenue from operations of ₹10,394 Cr (+18.4% YoY) and net profit of ₹1,486 Cr (+20.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,486 Cr · +20.6% YoY
Central Bank of India Other Announcement
Central Bank of India submitted its quarterly shareholding pattern under Regulation 31(1)(b). The bank also requested a two-year extension to meet minimum public shareholding requirements.
Other product launch announcements
All →HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum